Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 27.
doi: 10.1007/s40615-025-02523-5. Online ahead of print.

Disparities in Healthcare Providers' Substance Use Detection Practices for Pregnant Patients

Virginia Lijewski  1 , Heather Straub  2 , Kaylin Klie  3 , Sunah S Hwang  4 , Jeanelle Sheeder  2
Affiliations

Disparities in Healthcare Providers' Substance Use Detection Practices for Pregnant Patients

Virginia Lijewski et al. J Racial Ethn Health Disparities. .

Abstract

Objective: To assess providers' substance use screening/testing practices in patient care and identify disparities in their application. We hypothesized that patient race and social vulnerability (SV) are independently and jointly associated with increased rates of provider self-reported substance use screening/testing.

Methods: A 2 × 2 factorial vignette design was used to survey OB/GYN, Midwifery, and Family Medicine providers. The patients' age and medical characteristics were identical in each vignette, but two elements varied dichotomously: (1) the patient's race (Black vs. White) and (2) the patient's level of SV. Descriptive statistics were computed to assess respondent characteristics. Chi-square or Fisher's exact tests were performed to assess disparities in substance use screening/testing practices.

Results: Providers shown the SV patient vignette, compared to providers shown the vignette for a non-SV patient, reported that the patient's housing (41% vs. 10%, p < 0.01), substance use history (97% vs. 67%, p < 0.01), and the number of prenatal care visits (59% vs. 27%, p = 0.02) influenced their decision to screen/test the patient for substance use. Providers shown the vignette for the SV Black patient were more likely to report the patient's housing (47% vs. 6%, p = 0.04), substance use history (93% vs. 56%, p = 0.01), and gestational age (20% vs. 0%, p = 0.03) influenced their screening/testing recommendations.

Conclusion: Providers reported that the patient's level of SV influenced their decision to recommend screening/testing. The combination of race and SV had the largest impact on reported decisions regarding screening/testing practices. The results of this study highlight the need for standardized institutional substance use detection protocols to reduce provider bias and discrimination in substance use screening/testing based on individual patient demographics.

Keywords: Provider biases; Social vulnerability; Substance use screening and testing in pregnancy.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics Approval: This project was approved by the University of Colorado’s Institutional Review Board (COMIRB # 22–0929). Consent to Participate: Those who accessed the survey were notified via COMIRB postcard consent that completion of the survey questions indicated consent to participate in the research. Competing interests: The authors declare no competing interests.

Similar articles

See all similar articles

References

    1. Boden SL, Jones CW, Cabacungan ET. Improved maternal and infant outcomes with serial, self-reported early prenatal substance use screening. Matern Child Health J. 2021;25(7):1118–25. - DOI - PubMed
    1. American College of Obstetricians and Gynecologists, Committee Opinion No. 711 Summary: Opioid use and opioid use disorder in pregnancy. Obstetrics & Gynecology, 2017. 130(2):488–489.
    1. American College of Obstetricians and Gynecologists, Committee Opinion No. 633: Alcohol abuse and other substance use disorders: ethical issues in obstetric and gynecologic practice. Obstetrics & Gynecology, 2015. 125(6): p. 1529–1537.
    1. Patrick, S.W. and D.M. Schiff, A public health response to opioid use in pregnancy. Pediatrics, 2017. 139(3).
    1. Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health. 2020 July 1, 2023]; Table 6.21B – Illicit Drug Use, Marijuana Use, and Opioid Misuse in Past Month: Among Females Aged 15 to 44; by Pregnancy Status, Demographic, Socioeconomic, and Pregnancy Characteristics, Percentages, 2019 and 2020]. Available from: https://www.samhsa.gov/data/report/2020-nsduh-detailed-tables.

LinkOut - more resources